In this regard, performing a 6MWT can be used as a tool to improve HF diagnosis, as lower 6MWT distance may reflect a possible underlying HF diagnosis, as shown by the elevated NT-pro BNP and troponin levels among patients walking less than 345 m, both of which are well-established markers of cardiac dysfunction and heart failure20. This evidence concerns the gene NPPB and hydrops fetalis.